Article contents
A Trial of Fluphenazine Enanthate in Chronic Schizophrenia
Published online by Cambridge University Press: 29 January 2018
Extract
It has been shown by Parkes (1) and other workers that about 45 per cent. of out-patient schizophrenics are unreliable at taking their phenothiazine medication. It is in this group that many relapse and require readmission to hospital. Kline (2) quotes that 20 per cent. of in-patients are also unreliable in this regard. With the advent of a long-action phenothiazine injection fluphenazine enanthate, control of these difficult patients may well prove more effective.
- Type
- Abstract
- Information
- Copyright
- Copyright © Royal College of Psychiatrists, 1967
References
1.
Parkes, C. M., Brown, G. W., and Monck, E. M. (1962). Brit. med. J., i, 972.CrossRefGoogle Scholar
4.
National Institute of Health Multi-Centre Trial (1964). Arch. gen. Psychiat., 10, 246.CrossRefGoogle Scholar
6.
Hamilton, M., Smith, A. L. G., Lapidus, H. E., and Cadogan, E. P. (1960). J. ment. Sci., 106, 40.Google Scholar
- 9
- Cited by
eLetters
No eLetters have been published for this article.